CD86 and COVID-19: The dysregulation of DC function in COVID-19 was also presented by the expression of the maturation marker (CD83), T-cell stimulation molecules (CD40, CD80, CD86) and antigen presentation molecules (HLA-DQA2 and FCER1A) (Figure 5A).